Tango Therapeutics, Inc. (TNGX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.03B |
| Enterprise Value | 950.52M |
| P/E Ratio | -28.09 |
| PEG Ratio | -0.71 |
| Price/Sales Ratio | 72.25 |
| Price/Book Ratio | 3.49 |
| Enterprise/Revenue | 66.43 |
| Enterprise/EBITDA | -29.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.3 |
| Operating Margin | -2.53 |
| Return On Assets | -0.12 |
| Return On Equity | -0.26 |
| Revenue | 62.38M |
| Revenue/Share | 0.36 |
| Gross Profit | 60.1M |
| EBITDA | -99.31M |
| Net Income | -101.59M |
| Diluted EPS | -0.87 |
| Total Cash | 1.01B |
| Total Cash/Share | 6.77 |
| Total Debt | 31.99M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 50.82 |
| Book Value Per Share | 6.84 |
| 52-Week Change | 246.09 |
| 52-Week High | 34.39 |
| 52-Week Low | 6.25 |
| Moving Average 50 Days | 28.42 |
| Moving Average 200 Days | 18.81 |
| Average Volume | 3.81M |
| Shares Outstanding | 162.81M |
| % Held by Institutions | 149.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |